ENvue Medical (FEED) Common Equity (2014 - 2026)

ENvue Medical (FEED) has reported Common Equity for 13 consecutive years, with $30.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 24.01% year-over-year to $30.8 million in Q2 2026; TTM through Jun 2026 was $30.8 million, a 24.01% decrease from a year earlier, with the FY2025 full-year figure at $33.5 million, up 5242.42% from the prior year.
• Common Equity was $30.8 million for Q2 2026 at ENvue Medical, down from $32.0 million in the prior quarter.
• Over five years, Common Equity peaked at $42.5 million in Q3 2025 and troughed at $627000.0 in Q4 2024.
• A 5-year average of $14.0 million and a median of $4.1 million in 2022 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 84.28% in 2024 and jumped 5242.42% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $3.2 million in 2022, then gained by 23.38% to $4.0 million in 2023, then slumped by 84.28% to $627000.0 in 2024, then jumped by 5242.42% to $33.5 million in 2025, then fell by 8.18% to $30.8 million in 2026.
• The last three Common Equity figures came in at $30.8 million (Q2 2026), $32.0 million (Q1 2026), and $33.5 million (Q4 2025), per Business Quant data.